Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo

This publication has 23 references indexed in Scilit:

• Risk of rebound phenomenon during nitrate with drawal
  International Journal of Cardiology, 1994
• Clinical pharmacology of organic nitrates
  The American Journal of Cardiology, 1993
• The nitrovasodilators. New ideas about old drugs.
  Circulation, 1993
• Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats
  European Journal of Pharmacology, 1993
• Effects of L-NG-Monomethyl Arginine on the Cyclic GMP Formations in Rat Mesenteric Arteries.
  The Japanese Journal of Pharmacology, 1992
• Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast
  European Journal of Pharmacology, 1991
• Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
  Circulation, 1991
• Continuous Oral N-Acetycycsteine Treatment and Development of Nitrate Tolerance in Patients with Stable Angina Pectoris
  Journal of Cardiovascular Pharmacology, 1991
• Effect of nitrate tolerance and dipyridamole on the response to SIN1 in the human isolated saphenous vein
  Cardiovascular Drugs and Therapy, 1991
• Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover
  European Journal of Pharmacology, 1983